Animal models of Alzheimer's disease and evaluation of anti-dementia drugs

K Yamada, T Nabeshima - Pharmacology & therapeutics, 2000 - Elsevier
Alzheimer's disease (AD) is the most common cause of progressive decline of cognitive
function in aged humans, and is characterized by the presence of numerous senile plaques …

[PDF][PDF] Animal models of Alzheimer's disease and evaluation of anti-dementia drugs

K Yamada, T Nabeshima - Pharmacology & Therapeutics, 2000 - academia.edu
Alzheimer's disease (AD) is the most common cause of progressive decline of cognitive
function in aged humans, and is characterized by the presence of numerous senile plaques …

[引用][C] Animal models of Alzheimer's disease and evaluation of anti-dementia drugs

K Yamada, T Nabeshima - Pharmacology & Therapeutics, 2000 - cir.nii.ac.jp
Animal models of Alzheimer's disease and evaluation of anti-dementia drugs | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

Animal models of Alzheimer's disease and evaluation of anti-dementia drugs.

K Yamada, T Nabeshima - Pharmacology & Therapeutics, 2000 - europepmc.org
Alzheimer's disease (AD) is the most common cause of progressive decline of cognitive
function in aged humans, and is characterized by the presence of numerous senile plaques …

Animal models of Alzheimer's disease and evaluation of anti-dementia drugs

K Yamada, T Nabeshima - Pharmacology and Therapeutics, 2000 - infona.pl
Alzheimer's disease (AD) is the most common cause of progressive decline of cognitive
function in aged humans, and is characterized by the presence of numerous senile plaques …

Animal models of Alzheimer's disease and evaluation of anti-dementia drugs

K Yamada, T Nabeshima - Pharmacology and Therapeutics, 2000 - pure.fujita-hu.ac.jp
抄録 Alzheimer's disease (AD) is the most common cause of progressive decline of cognitive
function in aged humans, and is characterized by the presence of numerous senile plaques …

Animal models of Alzheimer's disease and evaluation of anti-dementia drugs

K Yamada, T Nabeshima - Pharmacology & therapeutics, 2000 - pubmed.ncbi.nlm.nih.gov
Alzheimer's disease (AD) is the most common cause of progressive decline of cognitive
function in aged humans, and is characterized by the presence of numerous senile plaques …

Animal models of Alzheimer's disease and evaluation of anti-dementia drugs

K Yamada, T Nabeshima - Pharmacology and Therapeutics, 2000 - infona.pl
Alzheimer's disease (AD) is the most common cause of progressive decline of cognitive
function in aged humans, and is characterized by the presence of numerous senile plaques …

Animal models of Alzheimer's disease and evaluation of anti-dementia drugs

K Yamada, T Nabeshima - Pharmacology and Therapeutics, 2000 - pure.fujita-hu.ac.jp
Alzheimer's disease (AD) is the most common cause of progressive decline of cognitive
function in aged humans, and is characterized by the presence of numerous senile plaques …

[引用][C] Animal models of Alzheimer's disease and evaluation of anti-dementia drugs

K YAMADA - Pharmacol. Ther., 2000 - cir.nii.ac.jp